Clinical Trial Update: Randomized Trial of Fluticasone in Bronchial Premalignancy [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 randomized trial evaluating inhaled fluticasone in bronchial premalignancy related to bronchogenic carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchogenic Carcinoma

Drugs mentioned

• Fluticasone (fluticasone propionate)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Bronchogenic Carcinoma | Phase 2 | Status: COMPLETED